ES2000491A6 - Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos - Google Patents

Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos

Info

Publication number
ES2000491A6
ES2000491A6 ES8600234A ES8600234A ES2000491A6 ES 2000491 A6 ES2000491 A6 ES 2000491A6 ES 8600234 A ES8600234 A ES 8600234A ES 8600234 A ES8600234 A ES 8600234A ES 2000491 A6 ES2000491 A6 ES 2000491A6
Authority
ES
Spain
Prior art keywords
equine
vaccine
equi
strain
virulent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600234A
Other languages
English (en)
Inventor
John F Timoney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
Original Assignee
Cornell Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc filed Critical Cornell Research Foundation Inc
Publication of ES2000491A6 publication Critical patent/ES2000491A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/829—Bacterial vaccine for equine species, e.g. horses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL METODO DESCRITO COMPRENDE SOMETER A MUTAGENESIS A UNA CEPA VIRULETA DE S.EQUI Y SELECCIONAR UNA BACTERIA RESULTANTE QUE PROPORCIONA UN FRAGMENTO DE PROTEINA -M DE UN PESO MOLECULAR DE 41.000. LA CEPA MUTADA ASI OBTENIDA, S.EQUI (709-27), ES UTIL PARA PREPARAR UNA NUEVA VACUNA BACTERIANA CONTRA EL GARROTILLO EN EQUINOS, LA CUAL ESTIMULA UNA RESPUESTA DE INMUNIDAD NASOFARINGEA MEDIANTE LA PRESENCIA DE ACTIVIDAD DE ANTICUERPOS EN EL MOCO NASOFARINGEO. LA VACUNA ES ADECUADA PARA ADMINISTRACION A UN EQUINO POR VIA INTRANASAL U ORAL Y ESTIMULA UNA RESPUESTA DE ANTICUERPOS EN LA MUCOSA NASOFARINGEA DEL EQUINO SUSCEPTIBLE A S.EQUI.
ES8600234A 1985-07-12 1986-07-10 Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos Expired ES2000491A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75461385A 1985-07-12 1985-07-12

Publications (1)

Publication Number Publication Date
ES2000491A6 true ES2000491A6 (es) 1988-03-01

Family

ID=25035573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600234A Expired ES2000491A6 (es) 1985-07-12 1986-07-10 Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos

Country Status (18)

Country Link
US (1) US5183659A (es)
EP (1) EP0230456B1 (es)
JP (1) JPH0816064B2 (es)
AR (1) AR241545A1 (es)
AT (1) ATE71532T1 (es)
AU (1) AU604645B2 (es)
CA (1) CA1281287C (es)
DE (1) DE3683478D1 (es)
DK (1) DK167599B1 (es)
ES (1) ES2000491A6 (es)
FI (1) FI87530C (es)
GR (1) GR861795B (es)
IE (1) IE58964B1 (es)
NO (1) NO169997C (es)
NZ (1) NZ216796A (es)
PT (1) PT82971B (es)
WO (1) WO1987000436A1 (es)
ZA (1) ZA865156B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2523883Y2 (ja) * 1992-02-24 1997-01-29 株式会社三協精機製作所 プーリ付調速器
ZA97452B (en) 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
EP0993469A1 (en) 1997-06-24 2000-04-19 John F. Timoney COMPOUNDS ENCODING THE PROTECTIVE M-LIKE PROTEIN OF $i(STREPTOCOCCUS EQUI) AND ASSAYS THEREFOR
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
US20070059327A2 (en) * 1998-01-15 2007-03-15 Wyeth Streptococcus equi compositions and methods of use
ES2214217T3 (es) * 1999-01-26 2004-09-16 Akzo Nobel N.V. Utilizacion de bacterias vivas atenuadas para la preparacion de una vacuna de administracion por la submucosa.
DK1560594T3 (da) 2002-10-11 2010-10-04 Bengt Guss Antigeniske sammensætninger til immunisering af ikke-menneskelige pattedyr mod Streptococcus equi
EP2227249B1 (en) 2007-12-13 2018-04-25 Intervacc AB Improved immunizing composition
ES2948841T3 (es) 2010-05-26 2023-09-20 Intervacc Ab Vacuna contra infecciones estreptocócicas basada en proteínas de fusión recombinantes
MX2016004961A (es) 2013-10-17 2016-06-28 Zoetis Services Llc Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
KR101694676B1 (ko) * 2015-12-10 2017-01-10 우진 비앤지 주식회사 말 선역 질병원인 국내 분리 스트렙토코커스 이콰이 균주 및 이를 포함하는 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3793150A (en) * 1971-01-20 1974-02-19 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
US3852420A (en) * 1971-01-20 1974-12-03 Richardson Merrell Inc Equine strangles vaccine and method of preparing and using the same
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
JPS60251898A (ja) * 1984-05-25 1985-12-12 Shiseido Co Ltd 醗酵法によるヒアルロン酸の製造方法
US4582798A (en) * 1984-11-23 1986-04-15 Miles Laboratories, Inc. Preparation and use of enzyme-detergent extracted Streptococcus equi vaccine

Also Published As

Publication number Publication date
PT82971B (pt) 1988-07-01
DE3683478D1 (de) 1992-02-27
NO169997C (no) 1992-09-02
FI87530B (fi) 1992-10-15
GR861795B (en) 1986-11-11
JPS63500596A (ja) 1988-03-03
EP0230456A4 (en) 1987-10-27
DK125887A (da) 1987-03-11
US5183659A (en) 1993-02-02
AU6149686A (en) 1987-02-10
AU604645B2 (en) 1991-01-03
NO871012L (no) 1987-03-11
IE861852L (en) 1987-01-11
DK167599B1 (da) 1993-11-29
NZ216796A (en) 1991-11-26
FI871060A0 (fi) 1987-03-11
EP0230456B1 (en) 1992-01-15
NO169997B (no) 1992-05-25
FI871060L (fi) 1987-03-11
JPH0816064B2 (ja) 1996-02-21
IE58964B1 (en) 1993-12-01
WO1987000436A1 (en) 1987-01-29
FI87530C (fi) 1993-01-25
CA1281287C (en) 1991-03-12
DK125887D0 (da) 1987-03-11
NO871012D0 (no) 1987-03-11
PT82971A (pt) 1986-08-01
ATE71532T1 (de) 1992-02-15
EP0230456A1 (en) 1987-08-05
ZA865156B (en) 1987-05-27
AR241545A1 (es) 1992-08-31

Similar Documents

Publication Publication Date Title
ES2000491A6 (es) Un metodo para producir una cepa de streptococcus equi que no es virulenta para equinos
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
ES2113882T3 (es) Vacuna oral que comprende un antigeno asociado superficialmente con eritrocitos.
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
WO1995006732A3 (en) Bacterial exported proteins and acellular vaccines based thereon
ATE219511T1 (de) Streptococcus equi impstoff
DK472988A (da) Terapeutiske praeparater mod streptokokinfektioner, transformerede vaerter og produkter fremstillet ved genteknologi
ATE182270T1 (de) Mukosale verabreichung von pneumokokken-antigenen
DK0833903T3 (da) Multivalent vaccine mod bovint coronavirus og fremgangsmåde til behandling af infektioner forårsaget af bovint coronavirus
LU90378I2 (fr) Tetravac
GB2227936A (en) Vaccine against brucella abortus
GB1354075A (en) Killed vaccine for infectious porcine atrophic rhinitis and process for preparing the same
DE3381554D1 (de) Kombination zur absorbierung verschiedener kationen.
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
BR8902109A (pt) Processo para aumentar a produtividade das porcas e alimentos
WO2002040515A3 (en) Exoenzyme toxin of aeromonas salmonicida, and uses thereof
DE68928061D1 (de) Expression von proteinsüssmitteln in hefe
ATE206138T1 (de) Helicobacter pylori antigen
ATE84722T1 (de) Tollwut-lebendimpfstoff.
NISHIMURA et al. Studies on type-specific streptococcal antibody in rheumatic heart disease
SU439956A1 (ru) Способ получени штаммов вирусов дл стимул ции интерфероногенеза
FR2580176B1 (fr) Vaccin antirabique avirulent
JPS55144894A (en) Preparation of microorganic lectin sml-91
Dzhidzheishvili et al. Study of the phosphatase activity of fibroblasts in the process of staphylococcal infection.
FR2099696A1 (en) Acidic glutaraldehyde soln for sterilising - contaminated objects

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20060711